HAMLET: functional properties and therapeutic potential. (October 2012)
- Record Type:
- Journal Article
- Title:
- HAMLET: functional properties and therapeutic potential. (October 2012)
- Main Title:
- HAMLET: functional properties and therapeutic potential
- Authors:
- Ho CS, James
Rydström, Anna
Trulsson, Maria
Bålfors, Johannes
Storm, Petter
Puthia, Manoj
Nadeem, Aftab
Svanborg, Catharina - Abstract:
- Human α-lactalbumin made lethal to tumor cells (HAMLET) is the first member in a new family of protein–lipid complexes that kills tumor cells with high selectivity. The protein component of HAMLET is α-lactalbumin, which in its native state acts as a substrate specifier in the lactose synthase complex, thereby defining a function essential for the survival of lactating mammals. In addition, α-lactalbumin acquires tumoricidal activity after partial unfolding and binding to oleic acid. The lipid cofactor serves the dual role as a stabilizer of the altered fold of the protein and a coactivator of specific steps in tumor cell death. HAMLET is broadly tumoricidal, suggesting that the complex identifies conserved death pathways suitable for targeting by novel therapies. Sensitivity to HAMLET is defined by oncogene expression including Ras and c-Myc and by glycolytic enzymes. Cellular targets are located in the cytoplasmic membrane, cytoskeleton, mitochondria, proteasomes, lysosomes and nuclei, and specific signaling pathways are rapidly activated, first by interactions of HAMLET with the cell membrane and subsequently after HAMLET internalization. Therapeutic effects of HAMLET have been demonstrated in human skin papillomas and bladder cancers, and HAMLET limits the progression of human glioblastomas, with no evidence of toxicity for normal brain or bladder tissue. These findings open up new avenues for cancer therapy and the understanding of conserved death responses in tumorHuman α-lactalbumin made lethal to tumor cells (HAMLET) is the first member in a new family of protein–lipid complexes that kills tumor cells with high selectivity. The protein component of HAMLET is α-lactalbumin, which in its native state acts as a substrate specifier in the lactose synthase complex, thereby defining a function essential for the survival of lactating mammals. In addition, α-lactalbumin acquires tumoricidal activity after partial unfolding and binding to oleic acid. The lipid cofactor serves the dual role as a stabilizer of the altered fold of the protein and a coactivator of specific steps in tumor cell death. HAMLET is broadly tumoricidal, suggesting that the complex identifies conserved death pathways suitable for targeting by novel therapies. Sensitivity to HAMLET is defined by oncogene expression including Ras and c-Myc and by glycolytic enzymes. Cellular targets are located in the cytoplasmic membrane, cytoskeleton, mitochondria, proteasomes, lysosomes and nuclei, and specific signaling pathways are rapidly activated, first by interactions of HAMLET with the cell membrane and subsequently after HAMLET internalization. Therapeutic effects of HAMLET have been demonstrated in human skin papillomas and bladder cancers, and HAMLET limits the progression of human glioblastomas, with no evidence of toxicity for normal brain or bladder tissue. These findings open up new avenues for cancer therapy and the understanding of conserved death responses in tumor cells. … (more)
- Is Part Of:
- Future oncology. Volume 8:Number 10(2012)
- Journal:
- Future oncology
- Issue:
- Volume 8:Number 10(2012)
- Issue Display:
- Volume 8, Issue 10 (2012)
- Year:
- 2012
- Volume:
- 8
- Issue:
- 10
- Issue Sort Value:
- 2012-0008-0010-0000
- Page Start:
- 1301
- Page End:
- 1313
- Publication Date:
- 2012-10
- Subjects:
- clinical studies -- conserved death pathways -- HAMLET -- novel cancer therapies -- protein folding -- protein–lipid complex -- tumor cell death -- tumor specificity
Oncology -- Periodicals
616.99405 - Journal URLs:
- http://www.futuremedicine.com/loi/fon ↗
http://www.futuremedicine.com/ ↗ - DOI:
- 10.2217/fon.12.122 ↗
- Languages:
- English
- ISSNs:
- 1479-6694
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4060.610420
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 17510.xml